Enterohemorrhagic escherichia coli O157:H7 shiga toxins inhibit gamma interferon-mediated cellular activation

Infection and Immunity

Volumn 80, Issue 7, 2012, Pages 2307-2315

  Ho, Nathan K ^a,b   Ossa, Juan C ^a   Silphaduang, Uma ^c   Johnson, Roger ^c   Johnson Henry, Kathene C ^a   Sherman, Philip M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; SHIGA TOXIN; STAT1 PROTEIN; TYROSINE;

ARTICLE; BACTERIUM CULTURE; CELL ACTIVATION; CELL STRAIN CACO 2; CELL STRAIN HEPG2; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI SEROTYPE O157:H7; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

BLOTTING, WESTERN; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIAL CELLS; ESCHERICHIA COLI O157; HUMANS; IMMUNE EVASION; INTERFERON-GAMMA; PHOSPHORYLATION; PROTEOME; SHIGA TOXINS; STAT1 TRANSCRIPTION FACTOR;

EID: 84864801038     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00255-12     Document Type: Article

References (50)

1. Abe H, Tatsuno I, Tobe T, Okutani A, Sasakawa C. 2002. Bicarbonate ion stimulates the expression of locus of enterocyte effacement-encoded genes in enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 70: 3500-3509.
2. Atalla HN, Johnson R, McEwen S, Usborne RW, Gyles CL. 2000. Use of a Shiga toxin (Stx)-enzyme-linked immunosorbent assay and immunoblot for detection and isolation of Stx-producing Escherichia coli from naturally contaminated beef. J. Food Prot. 63:1167-1172.
3. Averbuch D, Chapgier A, Boisson-Dupuis S, Casanova JL, Engelhard D. 2011. The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1. Pediatr. Infect. Dis. J. 30:352-355.
4. Bellmeyer A, et al. 2009. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin. Am. J. Physiol. Gastrointest. Liver Physiol. 297:G576 -581.
5. Bielaszewska M, et al. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11:671- 676.
6. Ceponis PJ, McKay DM, Ching JC, Pereira P, Sherman PM. 2003. Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect. Immun. 71:1396 -1404.
7. Chapgier A, et al. 2006. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J. Immunol. 176:5078 -5083.
8. Chen J, Johnson R, Griffiths M. 1998. Detection of verotoxigenic Escherichia coli by magnetic capture-hybridization PCR. Appl. Environ. Microbiol. 64:147-152.
9. Ching JC, Jones NL, Ceponis PJ, Karmali MA, Sherman PM. 2002. Escherichia coli Shiga-like toxins induce apoptosis and cleavage of poly-(ADP-ribose) polymerase via in vitro activation of caspases. Infect. Immun. 70:4669-4677.
10. Croxen MA, Finlay BB. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26 -38.
11. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
12. Dean P, Kenny B. 2009. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr. Opin. Microbiol. 12:101-109.
13. Didcock L, Young DF, Goodbourn S, Randall RE. 1999. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:9928 -9933.
14. DuPont HL. 2009. Clinical practice. Bacterial diarrhea. N. Engl. J. Med. 361:1560 -1569.
15. Dupuis S, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388 -391.
16. Frank C, et al. 2011. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in germany-preliminary report. N. Engl. J. Med. 365:1771-1780.
17. Golan L, Gonen E, Yagel S, Rosenshine I, Shpigel NY. 2011. Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models. Dis. Model Mech. 4:86 -94.
18. Hale L, Lazos O, Haines A, Thomas C. 2010. An efficient stress-free strategy to displace stable bacterial plasmids. Biotechniques 48:223-228.
19. Hamada D, Hamaguchi M, Suzuki KN, Sakata I, Yanagihara I. 2010. Cytoskeleton-modulating effectors of enteropathogenic and enterohemorrhagic Escherichia coli: a case for EspB as an intrinsically less-ordered effector. FEBS J. 277:2409 -2415.
20. Higgins LM, et al. 1999. Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285:588 -591.
21. Ho NK, Crandall I, Sherman PM. 2012. Identifying mechanisms by which Escherichia coli O157:H7 subverts interferon-gamma mediated signal transducer and activator of transcription-1 activation. PLoS One 7:e30145. doi:10.1371/journal.pone.0030145.
22. Holmes A, Muhlen S, Roe AJ, Dean P. 2010. The EspF effector, a bacterial pathogen's Swiss army knife. Infect. Immun. 78:4445- 4453.
23. Huang A, et al. 1986. Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19. J. Bacteriol. 166:375- 379.
24. Jandu N, et al. 2006. Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon. Infect. Immun. 74: 1809-1818.
25. Jandu N, et al. 2009. Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia. PLoS One 4:e4889. doi:10.1371/journal.pone.0004889.
26. Jandu N, et al. 2007. Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-gamma-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1. Microb. Pathog. 42:62-71.
27. Jones RM, Neish AS. 2011. Recognition of bacterial pathogens and mucosal immunity. Cell. Microbiol. 13:670-676.
28. Karmali MA, et al. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41:4930-4940.
29. Kuijper EJ, Soonawala D, Vermont C, van Dissel JT. 2011. Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4 in the Netherlands, May 2011. Euro Surveill. 16:pii:19897.
30. Landoni VI, et al. 2010. Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha. Infect. Immun. 78:1193-1201.
31. Lingwood CA, et al. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262:8834- 8839.
32. Long KZ, et al. 2010. Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect. Immun. 78:1221-1228.
33. Maluykova I, et al. 2008. Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells. Biochim. Biophys. Acta 1782:370 -377.
34. Nandan D, Reiner NE. 1995. Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect. Immun. 63:4495- 4500.
35. Obrig TG. 2010. Escherichia coli Shiga toxin mechanisms of action in renal disease. Toxins (Basel) 2:2769 -2794.
36. Pedron T, Sansonetti P. 2008. Commensals, bacterial pathogens and intestinal inflammation: an intriguing menage a trois. Cell Host Microbe 3:344 -347.
37. Peterson MD, Mooseker MS. 1992. Characterization of the enterocytelike brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J. Cell Sci. 102:581- 600.
38. Philpott DJ, McKay DM, Sherman PM, Perdue MH. 1996. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am. J. Physiol. 270:G634-645.
39. Rasko DA, et al. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N. Engl. J. Med. 365:709 -717.
40. Rietschel ET, Brade H. 1992. Bacterial endotoxins. Sci. Am. 267:54-61.
41. Rietschel ET, et al. 1993. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187:169 -190.
42. Riff JD, Callahan JW, Sherman PM. 2005. Cholesterol-enriched membrane microdomains are required for inducing host cell cytoskeleton rearrangements in response to attaching-effacing Escherichia coli. Infect. Immun. 73:7113-7125.
43. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. 2010. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50:1-14.
44. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163- 189.
45. Shea-Donohue T, Fasano A, Smith A, Zhao A. 2010. Enteric pathogens and gut function: role of cytokines and STATs. Gut Microbes 1:316 -324.
46. Spears KJ, Roe AJ, Gally DL. 2006. A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol. Lett. 255:187-202.
47. Tatsuno I, et al. 2000. Isolation and characterization of mini-Tn5Km2 insertion mutants of enterohemorrhagic Escherichia coli O157:H7 deficient in adherence to Caco-2 cells. Infect. Immun. 68:5943-5952.
48. Tesh VL, Ramegowda B, Samuel JE. 1994. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62:5085-5094.
49. Wong AR, et al. 2011. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80:1420- 1438.
50. Ziebell K, et al. 2008. Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains. Appl. Environ. Microbiol. 74:4314-4323.